医疗成像公司SpectraWAVE筹集了5000万美元的B轮资金,用于HyperVueTM成像系统的开发和商业扩张. Medical imaging company SpectraWAVE raises $50M in Series B funding for HyperVue™ Imaging System development and commercial expansion.

设在马萨诸塞州贝德福德的一家医疗成像公司SpetraWAVE,已经筹集了5 000万美元的B系列资金,用于加强其超VueTM成像系统,该系统协助诊断冠动脉疾病。 SpectraWAVE, a medical imaging company based in Bedford, Massachusetts, has raised $50 million in Series B funding to enhance its HyperVue™ Imaging System, which aids in diagnosing coronary artery disease. 投资者包括JJDC、S3风险投资公司等。 Investors include JJDC, S3 Ventures, and others. 这些资金将支持商业扩张和开发新的软件功能,包括无线生理附加功能。 The funds will support commercial expansion and the development of new software features, including a wire-free physiology add-on. HyperVue使用先进的成像技术来改善心脏手术期间的病人结果。 HyperVue uses advanced imaging techniques to improve patient outcomes during cardiac procedures.